Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
0.2313
-0.0130 (-5.32%)
At close: Oct 9, 2025, 4:00 PM EDT
0.2324
+0.0011 (0.48%)
Pre-market: Oct 10, 2025, 4:00 AM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $9.92 million as of October 10, 2025. Its market cap has increased by 595.88% in one year.
Market Cap
9.92M
Enterprise Value
8.58M
1-Year Change
595.88%
Ranking
Category
Stock Price
$0.23
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $61.26M to $9.92M, a decrease of -83.80%. That is a compound annual growth rate of -21.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 9, 2025 | 9.92M | 36.97% |
Dec 31, 2024 | 7.25M | -47.00% |
Dec 29, 2023 | 13.67M | -80.37% |
Dec 30, 2022 | 69.64M | 11.19% |
Dec 31, 2021 | 62.63M | -64.95% |
Dec 31, 2020 | 178.67M | 2,798.45% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Mar 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 762.01B |
Johnson & Johnson | 456.36B |
AbbVie | 408.46B |
UnitedHealth Group | 335.28B |
AstraZeneca | 266.44B |
Novo Nordisk | 261.01B |
Novartis AG | 255.35B |
Abbott Laboratories | 233.29B |